Table II. —Distribution of studies by limitations of functioning of rehabilitation interest (LFRI),2 disease phase, and rehabilitation setting.3-40.
| Parameter | Classification | Current update (38 studies) |
Total 3rd edition (186 studies) |
|||
|---|---|---|---|---|---|---|
| N. | % | Citation | N. | % | ||
| LFRI | Nervous system structures/functions | 11 | 28.9% | 3-13 | 31 | 16.7% |
| Respiratory structures/functions | 2 | 5.3% | 14, 15 | 55 | 29.6% | |
| Digestive functions | 2 | 5.3% | 16, 17 | 3 | 1.6% | |
| Cardiovascular functions | 0 | 0% | 4 | 2.2% | ||
| Any other body structure and function | 13 | 34.2% | 18-30 | 71 | 38.2% | |
| Any activity limitation and participation restriction | 10 | 26.3% | 31-40 | 22 | 11.8% | |
| Disease phase | Acute COVID-19 infection | 8 | 21.1% | 15-17, 21-23, 26, 39 | 21 | 11.3% |
| Ongoing symptomatic COVID-19 | 5 | 13.2% | 4, 8, 13, 25, 40 | 41 | 22.0% | |
| Post COVID-19 condition | 25 | 65.8% | 3, 5-7, 9-12, 14, 18-20, 24, 27-38 | 121 | 65.1% | |
| Impact of COVID-19 (any phase) on people with disability | 0 | 0% | 3 | 1.6% | ||
| Rehabilitation setting | Rehabilitation in acute care | 5 | 13.2% | 15-17, 23, 39 | 10 | 5.4% |
| Post-acute specialized | 2 | 5.3% | 30, 40 | 7 | 3.8% | |
| Post-acute general | 6 | 15.8% | 3, 4, 18, 25, 34, 36 | 14 | 7.5% | |
| Specialized outpatient | 2 | 5.3% | 12, 29 | 9 | 4.8% | |
| General outpatient | 0 | 0% | 2 | 1.1% | ||
| Home-care | 0 | 0% | 13 | 7.0% | ||
| Rehabilitation in social assistance | 0 | 0% | 1 | 0.5% | ||
| N/A * | 23 | 60.5% | 5-11, 13, 14, 19-22, 24, 26-28, 31-33, 35, 37, 38 | 130 | 69.9% | |
N/A: not applicable. *A high proportion of studies reported LFRI in COVID-19 survivors, without focusing on a rehabilitation program.